The trends are clear: Payers, Employers, and Patients across the nation are concerned about skyrocketing specialty claim costs. A few jaw-dropping facts quickly illustrate the pattern of rising costs. Specialty drugs are one of the fastest growing segments of the healthcare sector with specialty drug costs projected to represent 55% of all drug spend by 2020. However, most of the focus is on the pharmacy spend and overlooks approximately 50% of specialty drug spend that is occurring under a payer or plan sponsor medical benefit. How can these costs be managed without being a constant financial drain on your company resources?
Join Zelis Healthcare’s Dr. Steven Wolinsky for an exclusive webinar on mitigating the high cost of medical claims for your organization through technology and clinical expertise.